Vall D'Hebron Risk Score II for Myocardial Infarction and Cardiac Death

Overview

Journal Open Heart

Publisher BMJ Publishing Group

Specialty Cardiology & Vascular Diseases

Date 2023 Nov 7

PMID 37935561

Authors

Guillermo Romero-Farina

Santiago Aguade-Bruix

Ignacio Ferreira Gonzalez

Affiliations

Soon will be listed here.

Abstract

Objectives: The aim of this study was to create a new Vall d'Hebron Risk Score-II (VH-RS-II) for non-fatal myocardial infarction (MI) and/or cardiac death (CD), excluding patients with coronary revascularisation (CR) during the follow-up.

Methods: We analysed 5215 consecutive patients underwent gated single photon emission CT (SPECT); 2960 patients (age 64.2±11, male 58.1%) had no previous MI and/or CR, and 2255 patients (age 63.3±11, male 81.9%) had previous MI and/or CR. During a follow-up of 4.3±2.6 years, the cardiac event (MI and CD) was evaluated. This study was reviewed and approved by the ethics committee of our institution (number form trial register, PR(AG)168.2012). To obtain the predictor model, multivariate Cox regression analysis and multivariate logistic regression analysis were used. RS-VH-II was validated with 679 patients.

Results: In patients without previous MI and/or CR, age (HR: 1.01; p<0.001), diabetes (HR: 2.1, p=0.001), metabolic equivalent (METs) (HR: 0.89, p=0.038), ST segment depression (HR: 1.4, p=0.011), ejection fraction (EF) (HR: 0.97, p<0.001) and summed stress score (HR: 1.2, p<0.001) were the independent predictors of CE (C-statistic: 0.8). In patients with previous MI and/or CR, age (HR: 1.06, p<0.001), male (HR: 1.9, p=0.047), smoker (HR: 1.5, p=0.047), METs (HR: 0.8, p<0.001), ST segment depression (HR: 1.4, p=0.002), EF (HR: 0.96; p<0.001) and summed difference score (HR: 1.03, p=0.06) were the independent predictors of CE (C-statistic:0.8).

Conclusion: The VH-RS-II obtained from different clinical exercise and gated SPECT variables allow the risk stratification for MI and CD in patients with or without previous MI and/or CR in due form.

References

Anderson K, Odell P, Wilson P, Kannel W . Cardiovascular disease risk profiles. Am Heart J. 1991; 121(1 Pt 2):293-8. DOI: 10.1016/0002-8703(91)90861-b. View

Shaw L, Hachamovitch R, Peterson E, Lewin H, Iskandrian A, Miller D . Using an outcomes-based approach to identify candidates for risk stratification after exercise treadmill testing. J Gen Intern Med. 1999; 14(1):1-9. PMC: 1496439. DOI: 10.1046/j.1525-1497.1999.00273.x. View

Mark D, Shaw L, Harrell Jr F, Hlatky M, Lee K, Bengtson J . Prognostic value of a treadmill exercise score in outpatients with suspected coronary artery disease. N Engl J Med. 1991; 325(12):849-53. DOI: 10.1056/NEJM199109193251204. View

Pryor D, Harrell Jr F, Lee K, Califf R, Rosati R . Estimating the likelihood of significant coronary artery disease. Am J Med. 1983; 75(5):771-80. DOI: 10.1016/0002-9343(83)90406-0. View

Coppola W, Whincup P, Papacosta O, Walker M, Ebrahim S . Scoring system to identify men at high risk of stroke: a strategy for general practice. Br J Gen Pract. 1995; 45(393):185-9. PMC: 1239199. View

Tunstall-Pedoe H . The Dundee coronary risk-disk for management of change in risk factors. BMJ. 1991; 303(6805):744-7. PMC: 1671016. DOI: 10.1136/bmj.303.6805.744. View

Matsumoto N, Hirayama A . Clinical value of high duke treadmill score with myocardial perfusion SPECT. J Nucl Cardiol. 2015; 23(6):1301-1303. DOI: 10.1007/s12350-015-0187-3. View

DAgostino R, Russell M, Huse D, Ellison R, Silbershatz H, Wilson P . Primary and subsequent coronary risk appraisal: new results from the Framingham study. Am Heart J. 2000; 139(2 Pt 1):272-81. DOI: 10.1067/mhj.2000.96469. View

Romero-Farina G, Candell-Riera J, Aguade-Bruix S, Ferreira-Gonzalez I, Cuberas-Borros G, Pizzi N . Warranty periods for normal myocardial perfusion stress SPECT. J Nucl Cardiol. 2014; 22(1):44-54. DOI: 10.1007/s12350-014-9957-6. View

10.

. Relationship of blood pressure, serum cholesterol, smoking habit, relative weight and ECG abnormalities to incidence of major coronary events: final report of the pooling project. The pooling project research group. J Chronic Dis. 1978; 31(4):201-306. DOI: 10.1016/0021-9681(78)90073-5. View

11.

Alexander K, Shaw L, Shaw L, DeLong E, Mark D, Peterson E . Value of exercise treadmill testing in women. J Am Coll Cardiol. 1998; 32(6):1657-64. DOI: 10.1016/s0735-1097(98)00451-3. View

12.

Reiner Z, Catapano A, De Backer G, Graham I, Taskinen M, Wiklund O . ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J. 2011; 32(14):1769-818. DOI: 10.1093/eurheartj/ehr158. View

13.

Candell-Riera J, Ferreira-Gonzalez I, Marsal J, Aguade-Bruix S, Cuberas-Borros G, Pujol P . Usefulness of exercise test and myocardial perfusion-gated single photon emission computed tomography to improve the prediction of major events. Circ Cardiovasc Imaging. 2013; 6(4):531-41. DOI: 10.1161/CIRCIMAGING.112.000158. View

14.

Romero-Farina G, Aguade-Bruix S, Rodenas-Alesina E, Herrador L, Jordan P, Ferreira-Gonzalez I . Usefulness of the Vall d'Hebron Risk Score to stratify the risk of patients with ischemic cardiomyopathy. J Nucl Cardiol. 2022; 30(2):751-763. DOI: 10.1007/s12350-022-03074-6. View

15.

Epstein S . Implications of probability analysis on the strategy used for noninvasive detection of coronary artery disease. Role of single or combined use of exercise electrocardiographic testing, radionuclide cineangiography and myocardial perfusion imaging. Am J Cardiol. 1980; 46(3):491-9. DOI: 10.1016/0002-9149(80)90020-x. View

16.

Shaper A, Pocock S, Phillips A, Walker M . Identifying men at high risk of heart attacks: strategy for use in general practice. Br Med J (Clin Res Ed). 1986; 293(6545):474-9. PMC: 1341109. DOI: 10.1136/bmj.293.6545.474. View

17.

Pocock S, McCormack V, Gueyffier F, Boutitie F, Fagard R, Boissel J . A score for predicting risk of death from cardiovascular disease in adults with raised blood pressure, based on individual patient data from randomised controlled trials. BMJ. 2001; 323(7304):75-81. PMC: 34541. DOI: 10.1136/bmj.323.7304.75. View

18.

Diamond G, Forrester J . Analysis of probability as an aid in the clinical diagnosis of coronary-artery disease. N Engl J Med. 1979; 300(24):1350-8. DOI: 10.1056/NEJM197906143002402. View

19.

Vitola J, Wanderley Jr M, Cerci R, Pereira Neto C, Kormann O, Neto O . Outcome of patients with high-risk Duke treadmill score and normal myocardial perfusion imaging on spect. J Nucl Cardiol. 2015; 23(6):1291-1300. DOI: 10.1007/s12350-015-0156-x. View

20.

Romero-Farina G, Candell-Riera J, Aguade-Bruix S, Dorado D . A novel clinical risk prediction model for myocardial infarction, coronary revascularization, and cardiac death according to clinical, exercise, and gated SPECT variables (VH-RS). Eur Heart J Cardiovasc Imaging. 2019; 21(2):210-221. DOI: 10.1093/ehjci/jez078. View